NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 16,750
-50 (-0.30%)
At close: Aug 11, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 270.25 billion as of August 12, 2026. Its market cap has decreased by -25.17% in one year.
Market Cap
270.25B
Enterprise Value
258.00B
Revenue
404.26B
Ranking
n/a
PE Ratio
7.85
Stock Price
16,750.00
ChartMarket Cap Chart
Since November 14, 2018, NOVAREX's market cap has increased from 180.98B to 270.25B, an increase of 49.33%. That is a compound annual growth rate of 5.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 288.14B | 16.26% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 313.98B |
| HEM Pharma | 299.96B |
| Cosmax Nbt | 214.18B |
| DAE HWA Pharmaceutical | 192.68B |
| CellBion | 185.58B |
| Vivozon Pharmaceutical | 177.49B |
| GC WellBeing | 173.82B |
| Ahn-Gook Pharmaceutical | 150.59B |